Drug General Information |
Drug ID |
D09WKB
|
Former ID |
DAP001274
|
Drug Name |
Anisindione
|
Synonyms |
Anisindiona; Anisindionum; Miradon; Unidone; Anisin indandione; SPE 2792; Anisindiona [INN-Spanish]; Anisindione (INN); Anisindione [INN:BAN]; Anisindionum [INN-Latin]; Miradon (TN); 2-(4-Methoxy-phenyl)-indan-1,3-dione; 2-(4-Methoxyphenyl)-1H-indene-1,3(2H)-dione; 2-(4-Methoxyphenyl)indan-1,3-dione; 2-(4-methoxyphenyl)indene-1,3-dione; 2-(p-Methoxyphenyl)-1,3-indandione; 2-(p-Methoxyphenyl)indane-1,3-dione; 2-[4-(methyloxy)phenyl]-1H-indene-1,3(2H)-dione; 2-p-Anisyl-1,3-indandione; 2-para-Anisyl-1,3-indandione
|
Drug Type |
Small molecular drug
|
Therapeutic Class |
Anticoagulants
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
C16H12O3
|
InChI |
InChI=1S/C16H12O3/c1-19-11-8-6-10(7-9-11)14-15(17)12-4-2-3-5-13(12)16(14)18/h2-9,14H,1H3
|
InChIKey |
XRCFXMGQEVUZFC-UHFFFAOYSA-N
|
CAS Number |
CAS 117-37-3
|
PubChem Compound ID |
|
PubChem Substance ID |
3150799, 5141622, 7907525, 8149855, 8151491, 10505123, 11335511, 11360750, 11364249, 11366811, 11369373, 11372509, 11374125, 11377535, 11461722, 11484150, 11488243, 11491340, 11492538, 11495169, 14729672, 15391997, 26537315, 26612327, 26679795, 26748631, 26748632, 29221375, 46504660, 47291049, 47515233, 48035021, 48184919, 48415571, 49982247, 50086377, 50107437, 50609859, 51091788, 57288748, 57321195, 58000062, 85333593, 92124482, 92307614, 99301424, 103194851, 104121859, 104299892, 105534934
|
Target and Pathway |
References |